{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:27:03Z","timestamp":1792218423719,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1982,1,1]],"date-time":"1982-01-01T00:00:00Z","timestamp":378691200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1982]]},"DOI":"10.1007\/bf00265388","type":"journal-article","created":{"date-parts":[[2004,11,20]],"date-time":"2004-11-20T12:16:39Z","timestamp":1100952999000},"page":"103-109","source":"Crossref","is-referenced-by-count":51,"title":["Pharmacokinetics of dacarbazine (DTIC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules"],"prefix":"10.1007","volume":"9","author":[{"given":"H.","family":"Breithaupt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dammann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","unstructured":"Aigner K, Breithaupt H, Hundeiker M, Jungbluth A (1982) Tumor regression due to isolated DTIC perfusion of rabbit ears bearing VX2-carcinoma. Anticancer Research (accepted for publication)"},{"key":"CR2","unstructured":"Aigner K, Hild P, Breithaupt H, Hundeiker M, Merker G, Jungbluth A, Brodkorb J, Paul E, Illig L, Schwemmle K (1982) The isolated perfusion of the liver and extremities with DTIC. Tumor regression by direct cytotoxic effect of DTIC. Anticancer Research (accepted for publication)"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/0003-2697(78)90463-3","volume":"88","author":"DD Beal","year":"1978","unstructured":"Beal DD, Bryan GT (1978) Method for detection of 2-azahypoxanthine in human and rat urine. Anal Biochem 88:612","journal-title":"Anal Biochem"},{"key":"CR4","first-page":"377","volume":"10","author":"JA Benvenuto","year":"1979","unstructured":"Benvenuto JA, Hall SW, Farquhar D, Lu K, Loo TL (1979) High-pressure liquid chromatography in pharmacological studies of anticancer drugs. Chromatogr Sci 10:377","journal-title":"Chromatogr Sci"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0014-2964(75)90006-7","volume":"11","author":"G Bonadonna","year":"1975","unstructured":"Bonadonna G, Uslenghi C, Zucali R (1975) Recent trends in the medical treatment of Hodgkin's disease. Eur J Cancer 11:251","journal-title":"Eur J Cancer"},{"key":"CR6","first-page":"165","volume":"60","author":"RL Comis","year":"1976","unstructured":"Comis RL (1976) DTIC (NSC-45388) in malignant melanoma: A perspective. Cancer Treat Rep 60:165","journal-title":"Cancer Treat Rep"},{"key":"CR7","first-page":"175","volume":"55","author":"DH Cowan","year":"1971","unstructured":"Cowan DH, Bergsagel DE (1971) Intermittent treatment of metastatic melanoma with high-dose 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388). Cancer Chemother Rep 55:175","journal-title":"Cancer Chemother Rep"},{"key":"CR8","first-page":"352","volume-title":"Grundlagen der Pharmakokinetik","author":"FH Dost","year":"1968","unstructured":"Dost FH (1968) Grundlagen der Pharmakokinetik. Thieme, Stuttgart, p 352"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/1097-0142(197310)32:4<749::AID-CNCR2820320403>3.0.CO;2-1","volume":"32","author":"LH Einhorn","year":"1973","unstructured":"Einhorn LH, McBride CM, Luke JK, Caoili E, Gottlieb JA (1973) Intra-arterial infusion therapy with (5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (NSC-45388) for malignant melanoma. Cancer 32:749","journal-title":"Cancer"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/0006-2952(76)90072-1","volume":"25","author":"D Farquhar","year":"1976","unstructured":"Farquhar D, Loo TL, Gutterman JU, Mersh EM, Luna MA (1976) Inhibition of drug metabolizing enzymes in the rat afterBacillus Calmette-Gu\u00e9rin treatment. Biochem Pharmacol 25:1529","journal-title":"Biochem Pharmacol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/0006-2952(72)90384-X","volume":"21","author":"AH Gerulath","year":"1972","unstructured":"Gerulath AH, Loo TL (1972) Mechanism of action of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide in mammalian cells in culture. Biochem Pharmacol 21:2335","journal-title":"Biochem Pharmacol"},{"key":"CR12","first-page":"199","volume":"60","author":"JA Gottlieb","year":"1976","unstructured":"Gottlieb JA, Benjamin RS, Baker LH, O'Bryan RM, Sinkovics JG, Hoogstraten B, Quagliana JM, Rivkin SE, Boidey GP, Rodriguez V, Blumenschein GR, Saiki JH, Coltman C, Burgess MA, Sullivan P, Thigpen T, Bottomley R, Balcerzak S, Moon TE (1976) Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Cancer Treat Rep 60:199","journal-title":"Cancer Treat Rep"},{"key":"CR13","first-page":"144","volume":"18","author":"SW Hall","year":"1977","unstructured":"Hall SW, Benjamin RS, Gutterman JH, Farquhar D, Loo TL (1977) Clinical pharmacology of dacarbazine (DIC) following intensiveCorynebacterium parvum (CP) immunotherapy. Proc AACR\/ASCO 18:144","journal-title":"Proc AACR\/ASCO"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF01644930","volume":"8","author":"HM Hattingberg von","year":"1980","unstructured":"Hattingberg HM von, Brockmeier D (1980) The pharmacokinetic basis of optimal antibiotic dosage. Infection 8:21","journal-title":"Infection"},{"key":"CR15","first-page":"3106","volume":"35","author":"DL Hill","year":"1975","unstructured":"Hill DL (1975) Microsomal metabolism of triazenylimidazoles. Cancer Res 35:3106","journal-title":"Cancer Res"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0024-3205(69)90448-2","volume":"8","author":"GE Housholder","year":"1969","unstructured":"Housholder GE, Loo TL (1969) Elevated urinary excretion of 4-aminoimidazole-5-carboxamide in patients after intravenous injection of 4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide. Life Sci 8:533","journal-title":"Life Sci"},{"key":"CR17","first-page":"386","volume":"179","author":"GE Housholder","year":"1971","unstructured":"Housholder GE, Loo TL (1971) Disposition of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide, a new antitumor agent. J Pharmacol Exp Ther 179:386","journal-title":"J Pharmacol Exp Ther"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/030089167706300308","volume":"63","author":"AM Jortay","year":"1977","unstructured":"Jortay AM, Lejeune FJ, Kenis Y (1977) Regional chemotherapy of maxillofacial malignant melanoma with intracarotid artery infusion of DTIC. Tumori 63:299","journal-title":"Tumori"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/ardp.19793120703","volume":"312","author":"G Kazemifard","year":"1977","unstructured":"Kazemifard G, Moattar F, Zia H (1977) Vergleich der polarographischen und kolorimetrischen Methoden zur Bestimmung von Dacarbazin. Arch Pharm (Weinheim) 312:573","journal-title":"Arch Pharm (Weinheim)"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/jps.2600560824","volume":"56","author":"TL Loo","year":"1967","unstructured":"Loo TL, Stasswender EA (1967) Colorimetric determination of dialkyltriazenoimidazoles. J Pharm Sci 56:1016","journal-title":"J Pharm Sci"},{"key":"CR21","first-page":"2448","volume":"28","author":"TL Loo","year":"1968","unstructured":"Loo TL, Luce JK, Jardine JH, Frei E III (1968) Pharmacologic studies of the antitumor agent 5-(dimethyltriazeno)imidazole-4-carboxamide. Cancer Res 28:2448","journal-title":"Cancer Res"},{"key":"CR22","first-page":"149","volume":"60","author":"TL Loo","year":"1976","unstructured":"Loo TL, Housholder GE, Gerulath AH, Saunders PH, Farquhar D (1976) Mechanism of action and pharmacology studies with DTIC (NSC-45388). Cancer Treat Rep 60:149","journal-title":"Cancer Treat Rep"},{"key":"CR23","first-page":"843","volume":"59","author":"B McInnis","year":"1975","unstructured":"McInnis B, Kapadia A, El-Asfouri S, Loo TL (1975) Stochastic compartmental modeling of the disposition of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388). Cancer Chemother Rep 59:843","journal-title":"Cancer Chemother Rep"},{"key":"CR24","first-page":"465","volume":"56","author":"NS Mizuno","year":"1972","unstructured":"Mizuno NS, Humphrey EW (1972) Metabolism of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in human and animal tumor tissue. Cancer Chemother Rep 56:465","journal-title":"Cancer Chemother Rep"},{"key":"CR25","first-page":"125","volume":"60","author":"JA Montgomery","year":"1976","unstructured":"Montgomery JA (1976) Experimental studies at Southern Research Institute with DTIC (NSC-45388). Cancer Treat Rep 60:125","journal-title":"Cancer Treat Rep"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/cpt1971126955","volume":"12","author":"L Nathanson","year":"1971","unstructured":"Nathanson L, Wolter J, Horton J, Colsky J, Shnider BJ, Schilling A (1971) Characteristics of prognosis and response to an imidazole carboxamide in malignant melanoma. Clin Pharmacol Ther 12:955","journal-title":"Clin Pharmacol Ther"},{"key":"CR27","first-page":"1123","volume":"64","author":"KJ Pritchard","year":"1980","unstructured":"Pritchard KJ, Quirt IC, Cowan DH, Osoba D, Kutas GJ (1980) DTIC therapy in metastatic malignant melanoma: A simplified dose schedule. Cancer Treat Rep 64:1123","journal-title":"Cancer Treat Rep"},{"key":"CR28","unstructured":"Reuther P, Dommasch D, Fuhrmeister U, Krauseneck P, Mertens HG (1980) Intrathekale Dacarbazin-Therapie bei leptomeningealer Melanom-Metastasierung. Abstr. Jahresversammlung Deutsche Gesellschaft f\u00fcr Neurologie, Wiesbaden, p 90"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000250487","volume":"160","author":"T Ruzicka","year":"1980","unstructured":"Ruzicka T, Goerz G, Vizethum W, Kratka J (1980) Effects of intravenous and intracutaneousBacillus Calmette-Gu\u00e9rin application on the drug-metabolizing system of the liver. Dermatologica 160:135","journal-title":"Dermatologica"},{"key":"CR30","first-page":"1223","volume":"62","author":"MK Samson","year":"1978","unstructured":"Samson MK, Baker LH, Talley RW, Fraile RJ, McDonald B (1978) Phase I?II study of intermittent bolus administration of DTIC and actinomycin D in metastatic malignant melanoma. Cancer Treat Rep 62:1223","journal-title":"Cancer Treat Rep"},{"key":"CR31","first-page":"2464","volume":"34","author":"PP Saunders","year":"1974","unstructured":"Saunders PP, Chao LY (1974) Fate of the ring moiety of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide in mammalian cells. Cancer Res 34:2464","journal-title":"Cancer Res"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/1097-0142(1971)28:5<1161::AID-CNCR2820280512>3.0.CO;2-V","volume":"28","author":"ED Savlow","year":"1971","unstructured":"Savlow ED, Hall TC, Oberfield RA (1971) Intra-arterial therapy of melanoma with dimethyl triazenoimidazole carboxamide (NSC-45388). Cancer 28:1161","journal-title":"Cancer"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1021\/jo01053a060","volume":"27","author":"YF Shealy","year":"1962","unstructured":"Shealy YF, Krauth CA, Montgomery JA (1962) Imidazoles. I. Coupling reactions of 5-diazoimidazole-4-carboxamide. J Org Chem 27:2150","journal-title":"J Org Chem"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0041-008X(71)80026-1","volume":"18","author":"JL Skibba","year":"1971","unstructured":"Skibba JL, Bryan GT (1971) Methylation of nucleic acids and urinary excretion of14C-labeled 7-methylguanine by rats and man after administration of 4(5)-(3,3-dimethyl-1-triazeno) imidazole-5(4)-carboxamide. Toxicol Appl Pharmacol 18:707","journal-title":"Toxicol Appl Pharmacol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0006-2944(69)90006-4","volume":"3","author":"JL Skibba","year":"1969","unstructured":"Skibba JL, Beal DD, Bryan GT (1969) A sensitive method for the determination of plasma and urinary 4(5)-amino-5(4)-imidazolecarboxamide. Biochem Med 3:150","journal-title":"Biochem Med"},{"key":"CR36","first-page":"1944","volume":"29","author":"JL Skibba","year":"1969","unstructured":"Skibba JL, Ramirez G, Beal DD, Bryan GT (1969) Preliminary clinical trial and the physiologic disposition of 4(5)-(3,3-dimethyl-1-triazeno) imidazole-5(4)-carboxamide in man. Cancer Res 29:1944","journal-title":"Cancer Res"},{"key":"CR37","first-page":"147","volume":"30","author":"JL Skibba","year":"1970","unstructured":"Skibba JL, Beal DD, Ramirez G, Bryan GT (1970)N-Demethylation of the antineoplastic agent 4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide by rats and man. Cancer Res 30:147","journal-title":"Cancer Res"},{"key":"CR38","first-page":"93","volume":"64","author":"BS Yap","year":"1980","unstructured":"Yap BS, Baker LH, Sinkovics JG, Rivkin SE, Bottomley R, Thigpen T, Burgess MA, Benjamin RS, Bodey GP (1980) Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) in combination chemotherapy for the treatment of advanced sarcomas. Cancer Treat Rep 64:93","journal-title":"Cancer Treat Rep"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00265388.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00265388\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00265388","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T13:15:11Z","timestamp":1554297311000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00265388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1982]]}},"alternative-id":["BF00265388"],"URL":"https:\/\/doi.org\/10.1007\/bf00265388","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982]]}}}